Paige and OptraSCAN have announced a partnership to streamline the adoption of digital pathology technology in the United States, European Union countries and United Kingdom.
Beckman Coulter Life Sciences has shown its continuing commitment to the next generation of researchers and scientists with a call for registrations for its SPRI Grants for Genomic Research.
Laboratory professionals’ due diligence on the chemical products used in their diagnostic analysis work is increasingly vital, according to diagnostic stain and reagent manufacturer, Atom Scientific.
The Testing Times report reflects expert opinion that supporting more widespread use of rapid diagnostic technology should be a central aim of efforts to tackle the next hidden pandemic.
Torrey Pines Scientific has launched its new EchoTherm Model HS70 corrosion-resistant fully programmable digital stirring hot plates.
Understanding where and how protein spikes invade healthy cells could advance the fight against COVID-19 and other viral illnesses.
AetherAI, Asia’s leading medical image AI solution provider, has designed an AI-assisted lymph node assessment workflow, validated with clinical experiments, and revealed the improvement of micrometastasis identification sensitivity from 81% to 95%.
The company’s newest osmometer delivers the automation and data management capabilities modern clinical laboratories require to free up staff time, improve result turnaround times, reduce errors, and ensure effortless compliance.
Grail has announced final results from the interventional Pathfinder study, which evaluated multi-cancer early detection (MCED) screening using a blood test and the clinical care pathways following a “cancer signal detected” MCED test result in 6,662 individuals aged 50 years or older, an age group at elevated risk for cancer.
Image data from multiple hospitals improves the tool’s versatility and accuracy.
Deciphex, a leading provider of digital pathology software and services, has launched its Diagnexia service in the United States.
Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, and Nucleai, a leader in AI-powered spatial biology transforming precision medicine by unlocking the power of pathology data, hav announced a collaboration to accelerate the discovery of novel biomarkers and drug targets using the latest spatial imaging and machine learning technologies.
PhoreMost will deploy its Siteseeker platform to identify novel targets for Roche’s discovery programmes.
A laboratory service in a local hospital in West Bengal, India, is continuing to benefit from UK support offered by Mast Group and others post-COVID.